Shigeharu Tanayama

Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.

Yoshihiro Maeshiba, Yoshihiro Kiyota, Kenji Yamashita et al. · PubMed · 1997 · 139 citations

Pharmacological Study, Pharmacology, Radioactivity Dose +11

Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs.

Hiroshi Torii, Kiyoshi Yoshida, Takuo Kobayashi et al. · Journal of Pharmacobio-Dynamics · 1985 · 51 citations · Full text

Dogs Excretion, New Cerebral Metabolism, 14C-labeled Idebenone +21

Characterization of Conjugated Metabolites of a New Angiotensin II Receptor Antagonist, Candesartan Cilexetil, in Rats by Liquid Chromatography/Electrospray Tandem Mass Spectrometry Following Chemical Derivatization

Takahiro Kondo, Kiyoshi Yoshida, Yoshinobu Yoshimura et al. · Journal of Mass Spectrometry · 1996 · 48 citations

Pharmacotherapy, Experimental Pharmacology, Medicinal Chemistry +16

Biotransformation of Molsidomine (<i>N</i>-Ethoxycarbonyl-3-morpholinosydnonimine), a New Anti-anginal Agent, in Rats

Shigeharu Tanayama, Yoichi Nakai, Takeshi Fujita et al. · Xenobiotica · 1974 · 47 citations

Blood Molsidomine Level, Pharmacotherapy, Experimental Pharmacology +18

Brain distribution of idebenone and its effect on local cerebral glucose utilization in rats

Yasuo Nagai, Kiyoshi Yoshida, Shigehiko Narumi et al. · Archives of Gerontology and Geriatrics · 1989 · 41 citations

Neurophysiology, Neuroanatomy, Medicine +9